Rethinking medications : truth, power, and the drugs you take / Jerry Avorn, MD.
"Groundbreaking research has given us many remarkable new medicines, but America's drug evaluation process, once the envy of the world, is being seriously compromised. Under pressure from drugmakers, the FDA has been lowering its approval standards and has let poorly effective or risky products enter the market- while our prescription prices, the highest in the world, put crucial treatments beyond the reach of many. In Rethinking Medications, Dr. Jerry Avorn explains how we got here and what we can do to ensure that our medicines are dependably effective, safe, and affordable"-- Provided by publisher.
Record details
- ISBN: 1668052849
- ISBN: 9781668052846
- Physical Description: x, 498 pages ; 24 cm.
- Edition: First Simon & Schuster hardcover edition.
- Publisher: New York : Simon & Schuster, 2025.
- Copyright: ©2025
Content descriptions
- Bibliography, etc. Note:
- Includes bibliographical references (pages 455-478) and index.
- Formatted Contents Note:
- Introduction: A friend of the court -- Part one: Does it work?. How do we know? ; Decision-making and dementia ; Lowering the bar ; Standards that matter to patients -- Part two: Is it safe?. How do we find out about drug risks? ; Downfall of a giant ; Texas hold'em ; The label as protective talisman ; A new era of reform -- Part three: What should it cost?. The price of a wonder drug ; Giving it all away ; A license to print money ; Old whines in new battles ; Conflicted interests ; Making medicines affordable -- Part four: Spreading the word. A failure to communicate ; Shaping the prescribers of tomorrow ; Better signals -- Part five: Mind-altering examples. Acid reflux : the death and rebirth of psychedelics ; Pain, killers -- Part six. Empowering the patient. You can't get medicines if you can't get health care -- Epilogue: Healing the wounds -- Appendix A: Resources for consumers -- Appendix B: A note to health-care professionals and trainees -- Acknowledgements -- Notes -- Index.
Search for related items by subject
Available copies
- 13 of 13 copies available at NC Cardinal. (Show)
- 1 of 1 copy available at Onslow County Public Library.
Holds
- 0 current holds with 13 total copies.
Show Only Available Copies
| Location | Call Number / Copy Notes | Barcode | Shelving Location | Status | Due Date |
|---|---|---|---|---|---|
| Jacksonville Main Library | 338.4761 AVO (Text) | 36015000491320 | Adult Nonfiction | Available | - |
Accessibility Features
| LDR | 02844nam a2200337 4500 | ||
|---|---|---|---|
| 001 | 14781845 | ||
| 003 | CARDINAL | ||
| 005 | 20250210013143.0 | ||
| 008 | 250210t20252025nyu e b 000 0 eng d | ||
| 020 | . | ‡a1668052849 ‡q(hardcover) | |
| 020 | . | ‡a9781668052846 ‡q(hardcover) | |
| 035 | . | ‡a(OCoLC)1514912035 | |
| 043 | . | ‡an-us--- | |
| 050 | 1 | 4. | ‡aHD9666.5 ‡b.A96 2025 |
| 082 | . | ‡a338.4/761510973 ‡223 | |
| 100 | 1 | . | ‡aAvorn, Jerry, ‡eauthor. ‡0(CARDINAL)654934 |
| 245 | 1 | 0. | ‡aRethinking medications : ‡btruth, power, and the drugs you take / ‡cJerry Avorn, MD. |
| 250 | . | ‡aFirst Simon & Schuster hardcover edition. | |
| 264 | 1. | ‡aNew York : ‡bSimon & Schuster, ‡c2025. | |
| 264 | 4. | ‡c©2025 | |
| 300 | . | ‡ax, 498 pages ; ‡c24 cm. | |
| 336 | . | ‡atext ‡btxt ‡2rdacontent | |
| 337 | . | ‡aunmediated ‡bn ‡2rdamedia | |
| 338 | . | ‡avolume ‡bnc ‡2rdacarrier | |
| 504 | . | ‡aIncludes bibliographical references (pages 455-478) and index. | |
| 505 | 0 | 0. | ‡gIntroduction: ‡tA friend of the court -- ‡gPart one: ‡tDoes it work?. ‡tHow do we know? ; ‡tDecision-making and dementia ; ‡tLowering the bar ; ‡tStandards that matter to patients -- ‡tPart two: ‡tIs it safe?. ‡tHow do we find out about drug risks? ; ‡tDownfall of a giant ; ‡tTexas hold'em ; ‡tThe label as protective talisman ; ‡tA new era of reform -- ‡gPart three: ‡tWhat should it cost?. ‡tThe price of a wonder drug ; ‡tGiving it all away ; ‡tA license to print money ; ‡tOld whines in new battles ; ‡tConflicted interests ; ‡tMaking medicines affordable -- ‡gPart four: ‡tSpreading the word. ‡tA failure to communicate ; ‡tShaping the prescribers of tomorrow ; ‡tBetter signals -- ‡gPart five: ‡tMind-altering examples. ‡tAcid reflux : the death and rebirth of psychedelics ; ‡tPain, killers -- ‡gPart six. ‡tEmpowering the patient. ‡tYou can't get medicines if you can't get health care -- ‡gEpilogue: ‡tHealing the wounds -- ‡tAppendix A: Resources for consumers -- ‡tAppendix B: A note to health-care professionals and trainees -- ‡gAcknowledgements -- ‡gNotes -- ‡gIndex. |
| 520 | . | ‡a"Groundbreaking research has given us many remarkable new medicines, but America's drug evaluation process, once the envy of the world, is being seriously compromised. Under pressure from drugmakers, the FDA has been lowering its approval standards and has let poorly effective or risky products enter the market- while our prescription prices, the highest in the world, put crucial treatments beyond the reach of many. In Rethinking Medications, Dr. Jerry Avorn explains how we got here and what we can do to ensure that our medicines are dependably effective, safe, and affordable"-- ‡cProvided by publisher. | |
| 650 | 0. | ‡aPharmaceutical industry ‡zUnited States. ‡0(CARDINAL)297927 | |
| 650 | 0. | ‡aPrescription pricing ‡zUnited States. ‡0(CARDINAL)300728 | |
| 650 | 0. | ‡aDrugs ‡xPrescribing ‡zUnited States. ‡0(CARDINAL)296771 | |
| 901 | . | ‡a14781845 ‡bAUTOGEN ‡c14781845 ‡tbiblio ‡soclc | |
